"The University of Arizona Cancer Center is designated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center. This designation, the NCI’s highest, is reserved for centers focusing on patient care, research, prevention, education, outreach and training."

During the past decade, University of Arizona Cancer Center-Orange Grove Campus conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 23 clinical trials were completed, i.e. on average, 53.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 12 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arizona Cancer Center-Orange Grove Campus" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "NRG Oncology" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arizona Cancer Center-Orange Grove Campus" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "University of Arizona Cancer Center-Orange Grove Campus" are "Colorectal Cancer" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Anatomic Stage IV Breast Cancer AJCC v8" (2 trials), "Breast Cancer" (2 trials) and "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "University of Arizona Cancer Center-Orange Grove Campus" in a lesser frequency.

Most popular intervention types in "University of Arizona Cancer Center-Orange Grove Campus" are "Drug" (56 trials), "Other" (32 trials), "Biological" (26 trials), "Procedure" (19 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Carboplatin" (8 trials), "Cisplatin" (8 trials), "Quality-of-Life Assessment" (8 trials) and "Computed Tomography" (7 trials). Other intervention names were less common.

The vast majority of trials in "University of Arizona Cancer Center-Orange Grove Campus" are 54 trials for "All" genders, 7 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "University of Arizona Cancer Center-Orange Grove Campus". undefined are not yet recruiting, 24 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in University of Arizona Cancer Center-Orange Grove Campus, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Arizona Cancer Center-Orange Grove Campus, 3 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".